MEIQI ZENG

Mrs. MEIQI ZENG


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
kaifang Wangkaifang Wang
kaifang Wang
XWXiaona Wang
Xiaona Wang
MZMinghuan Zhang
Minghuan Zhang
ZYZhenguang Ying
Zhenguang Ying
ZZZeyao Zhu
Zeyao Zhu
OSOu Sha
Ou Sha
Trichosanthin (TCS) is a type I ribosome-inactivating protein extracted from the tuberous root of the plant Trichosanthes. TCS shows promising potential in clinical drug abortion, anti-tumor and immunological regulation. However, the molecular mechanisms of its anti-tumor and immune regulation properties are still not well discovered. In the present study, we investigated the anti-tumor activity of TCS in hepatocellular carcinoma (HCC), both in vitro and in vivo. Both HCC cell lines and xenograft tumor tissues showed considerable growth inhibition after they were treated with TCS. TCS provoked caspase-mediated apoptosis in HCC cells and xenograft tumor tissues. The recruitment of CD8+ T cells to HCC tissues and the expression of chemokines, CCL2 and CCL22, were promoted upon TCS treatment. In addition, TCS induced an upregulation of Granzyme B (GrzB), TNF-α and IFN-γ in HCC tissues, which are the major cytotoxic mediators produced by T cells. Furthermore, TCS also resulted in an increase of mannose-6-phosphate receptor (M6PR), the major receptor of GrzB, in HCC tissues. In summary, these results suggest that TCS perhaps increases T-cell immunity via promoting the secretion of chemokines and accelerating the entry of GrzB to HCC cells, which highlights the potential role of TCS in anti-tumor immunotherapy.

21 November 2023 in Genome Instability & Disease
Verified
Journal Article
Closed access
PDF file
MZMEIQI ZENG
MEIQI ZENG
XWXia Wang
Xia Wang
XWXiaona Wang
Xiaona Wang
YZYuning Zhang
Yuning Zhang
ZYZhenguang Ying
Zhenguang Ying
OSOu Sha
Ou Sha